USO DA CÚRCUMA COMO ADJUVANTE NO TRATAMENTO DO DIABETES MELLITUS: UMA REVISÃO DA LITERATURA
DOI:
https://doi.org/10.47820/recima21.v4i10.4127Palavras-chave:
Diabetes mellitus, cúrcuma longa, controle glicêmico.Resumo
O diabetes mellitus (DM) é um problema de saúde mundial que atingiu níveis alarmantes, onde quase meio bilhão de pessoas vivem com a doença atualmente. Diversos tratamentos são usados para o controle do DM, seja a monoterapia ou associações terapêuticas, dentre estes inclui-se o uso de antidiabéticos orais e fitoterápicos. Nesse contexto a cúrcuma surge como uma alternativa terapêutica potencial como adjuvante no tratamento do DM. Com suas ações antioxidantes, anti-inflamatórias e hipoglicêmicas, a cúrcuma longa demonstra atividade não só no controle do diabetes mellitus tipo 2, mas também em suas complicações como a nefropatia diabética. A biodisponibilidade por via oral da cúrcuma enfrenta adversidades por conta da sua baixa absorção, distribuição tecidual limitada, meia-vida curta e rápida velocidade de biotransformação hepática, sendo este um fator limitante para aprovação clínica. O artigo faz uma revisão atual sobre os principais aspectos do uso da cúrcuma como adjuvante no tratamento do DM e conclui que esta planta apresenta propriedades benéficas aos pacientes diabéticos.
Downloads
Referências
AGARWAL, Anil K. et al. New Insight into the Molecular Drug Target of Diabetic Nephropathy. Indonesia: University of Indonesia, 2014.
ALBERTI, K. G. et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Diabetes Care, v. 29, n. 7, p. 1860-1866, 2006.
ALCALDE, M. T.; DEL POZO, A. Nuevos despigmentantes cutâneos (XII). Tetrahidrocurcuminóides. OFFARM, v. 27, n. 5, p. 130-131, 2008.
ALMEIDA, L. P. Caracterização de pigmentos da Curcuma longa, L., avaliação da atividade antimicrobiana, morfogênese in vitro na produção de curcuminóides e óleos essenciais. Dissertação de Doutorado. Faculdade de Farmácia da Universidade Federal de Minas Gerais, Belo Horizonte, 2006.
ALMEIDA, T.; CRUZ, S. C. Neuropatia diabética. Revista Portuguesa de Medicina Geral e Familiar, v. 23, n. 5, p. 605-613, 2007.
ANJOMSHOA, S.; NAMAZIAN, M.; NOORBALA, M. R. The Effect of Solvent on Tautomerism, Acidity and Radical Stability of Curcumin and Its Derivatives Based on Thermodynamic Quantities. Journal of Solution Chemistry, v. 45, p. 1021, 2016. https://doi.org/10.1007/s10953-016-0481-y
ARAUJO, C. A. C.; LEON, L. L. Biological activities of Curcuma longa L. Memórias do Instituto Oswaldo Cruz, Rio de Janeiro, v. 96, n. 5, p. 723-728, 2001.
AZIMI-NEZHAD, M. et al. High prevalence of metabolic syndrome in Iran in comparison with France: what are the components that explain this? Metabolic Syndrome and Related Disorders, v. 10, n. 2, p. 181-188, 2012.
AZIZ, M. T. et al. The effect of curcumin on insulin release in rat-isolated pancreatic islets. Angiology, v. 61, n. 6, p. 557-566, 2010.
AGGARWAL, B. B.; SUNG, B. Pharmacological basis for the role of curcumin in chronic diseases: an age-old spice with modern targets. Trends in Pharmacological Sciences, v. 30, n. 2, p. 85-94, 2009.
ALONSO, J. Curcuma. In: ALONSO, J. Tratado de Fitofarmácos e Nutracêuticos. São Paulo: A C Farmacêutica, 2016. p. 364-373.
BASTOS, D. H. M.; ROGERO, M. M.; ARÊAS, J. A. G. Mecanismos de ação de compostos bioativos dos alimentos no contexto de processos inflamatórios relacionados à obesidade. Arquivos Brasileiros de Endocrinologia e Metabologia, v. 53, n. 5, p. 646-656, 2009.
BENJAMIN, E. J. et al. Heart Disease and Stroke Statistics - Update: Chapter 10. A report from the American Heart Association. Circulation, v. 139, e157a 177a, 2019.
BIBLIOTECA VIRTUAL EM SAÚDE, Ministério da Saúde. Disponível em: https://bvsms.saude.gov.br/diabetes/. Acesso em: 25 jul. 2022.
BOSCO, A. et al. Retinopatia diabética. Arquivos Brasileiros de Endocrinologia & Metabologia, v. 49, p. 217-227, 2005.
CHEN, C. et al. An in vitro study of liposomal curcumin: Stability, toxicity and biological activity in human lymphocytes and Epstein-Barr virus-transformed human B-cells. International Journal of Pharmaceutics, v. 366, p. 133-139, 2009.
CHEN, Fang-Pei et al. The Metabolic Syndrome Is Associated with an Increased Risk of Colorectal Polyps Independent of Plasma Homocysteine. Annals of Nutrition and Metabolism, v. 64, p. 106-112, 2014.
CHOI, B. H.; KANG, K. S.; KWAK, M. K. Effect of Redox Modulating NRF2 Activators on Chronic Kidney Disease – Korea: 2014. Disponível em: http://www.mdpi.com/1420-3049/19/8/12727/htm#B191-molecules-19-12727. Acesso em: 20 jul. 2022.
CHUENGSAMARN, S. et al. Curcumin extract for prevention of type 2 diabetes. Diabetes Care, v. 35, p. 2121-2127, 2012.
DE MORAES, C. A.; COLICIGNO, P. R. C.; SACCHETTI, J. C. L. Nefropatia diabética. Ensaios e Ciência: Ciências Biológicas, Agrárias e da Saúde, v. 13, n. 1, p. 133-143, 2009.
DIRETRIZ BRASILEIRA DE DIAGNÓSTICO E TRATAMENTO DA SÍNDROME METABÓLICA. Arquivos Brasileiros de Cardiologia - Volume 84, Suplemento I, Abril 2005.
DiSilvestro, R. A. et al. Diverse effects of a low dose supplement of lipidated curcumin in healthy middle-aged people. BMC, v. 11, n. 79, 2012.
EXECUTIVE SUMMARY OF THE THIRD REPORT OF THE NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP) EXPERT PANEL ON DETECTION, EVALUATION, AND TREATMENT OF HIGH BLOOD CHOLESTEROL IN ADULTS (ADULT TREATMENT PANEL III). JAMA, v. 285, n. 19, p. 2486-2497, 2001.
GHASEMIAN, Mona; OWLIA, Mohammad Bagher; OWLIA, Sina. Review of Anti-Inflammatory Herbal Medicines. Advances in Pharmacological Sciences, ISSN 1687-6342, 2016, p. 11.
GISELE LIMA NOGUEIRA SOLER et al. Nonalcoholic Fatty Liver Disease: association with metabolic syndrome and cardiovascular risk factors. Revista da SOCERJ, v. 21, n. 2, p. 94-100, 2008.
GOLDENBERG, Ronald; PUNTHAKEE, Zubin. Definition, classification and diagnosis of diabetes, prediabetes and metabolic syndrome. Canadian Journal of Diabetes, v. 37, p. S8-S11, 2013.
GÓNGORA, L. et al. Effects of caffeoyl conjugates of isoprenyl-hydroquinone glucoside and quinic acid on leukocyte function. Life Sciences, v. 71, n. 25, p. 2995-3004, 2002.
GOWTHAMARAJAN, K.; KARRI, V. V. S. R.; MN, S. K.; MALAYANDI, R. Multiple Biological Actions of Curcumin in the Management of Diabetic Foot Ulcer Complications: A Systematic Review. Tropical Medicine and Surgery, v. 3, p. 1-6, 2015.
GRANDI, T. S. M. Tratado das plantas medicinais: Mineiras, Nativas e Cultivadas. Belo Horizonte: Adaequatio Estúdio, 2014, p. 1076-1077.
GRUNDY, S. M. Metabolic syndrome pandemic. Arteriosclerosis, Thrombosis, and Vascular Biology, v. 28, p. 629-636, 2008.
GRUNDY, S. M. Metabolic syndrome update. Trends in Cardiovascular Medicine, v. 26, p. 364-373, 2016.
GRUNDY, S. M. et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement. Circulation, v. 112, n. 17, p. 2735-2752, 2005.
GUTIERRES, V. O. et al. Curcumin pharmacokinetic and pharmacodynamic evidences in streptozotocin-diabetic rats support the antidiabetic activity to be via metabolite(s). Evidence-Based Complementary and Alternative Medicine, 2015.
HARDING, J. et al. The metabolic syndrome and cancer: Is the metabolic syndrome useful for predicting cancer risk above and beyond its individual components? Diabetes & Metabolism, 2015.
HERNÁNDEZ-CAMACHO, J. D.; HERNÁNDEZ-CAMACHO, M. Clinical update on metabolic syndrome. Rev Esp Nutr Hum Diet, v. 21, p. 94-102, 2017.
INSTITUTO VIDA VASCULAR (IVV). Disponível em: https://www.vidavascular.com.br/doenca-vascular-diabetica/#tab-id-4. Acesso em: 10/06/2022.
ISMAIL, N. A. et al. Effect of oral curcumin administration on insulin resistance, serum resistin and fetuin-A in obese children: randomized placebo-controlled study. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2014.
KHAJEHDEHI, P. et al. Oral supplementation of turmeric attenuates proteinuria, transforming growth factor-β and interleukin-8 levels in patients with overt type 2 diabetic nephropathy: a randomized, double-blind and placebo-controlled study. Shiraz University of Medical Sciences, 2011.
KONG, L. D.; CHEN, Y.; YU, Z. F. Antidepressant activity of aqueous extracts of Curcuma longa in mice. Journal of Ethnopharmacology, v. 83, n. 1-2, p. 161-165, Nov 2002.
KIM, M. H.; KIM, S. H.; YANG, W. M. Mechanisms of action of phytochemicals from medicinal herbs in the treatment of Alzheimer's disease. Planta Medica, v. 80, n. 15, p. 1249-1258, Oct 2014.
LAKKA, H. M. et al. The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men. JAMA, v. 288, n. 21, p. 2709-2716, 2002.
LIRA NETO, J. C. G. et al. Prevalence of the metabolic syndrome and its components in people with type 2 diabetes mellitus. Revista Brasileira de Enfermagem, v. 70, n. 2, p. 265-270, 2017.
LX, Na et al. Curcuminoids exert glucose-lowering effect in type 2 diabetes by decreasing serum free fatty acids: a double-blind, placebo-controlled trial. Molecular Nutrition & Food Research, v. 57, p. 1569-1577, 2013.
MAITI, K. et al. Curcumin–phospholipid complex: Preparation, therapeutic evaluation and pharmacokinetic study in rats. International Journal of Pharmaceutics, v. 330, n. 1-2, p. 155-163, 2007.
MALDONADO-ROJAS, W.; OLIVERO-VERBEL, J. Potential interaction of natural dietary bioactive compounds with COX-2. Journal of Molecular Graphics and Modelling, v. 30, p. 157-166, 2011.
MAJITHIYA, J. B. et al. Effect of bis[curcumino] oxovanadium complex on nondiabetic and streptozotocin-induced diabetic rats. Journal of Trace Elements in Medicine and Biology, v. 18, n. 3, p. 211-217, 2005.
MANIKANDAN, R. et al. Anti-cataractogenic effect of curcumin and aminoguanidine against selenium-induced oxidative stress in the eye lens of Wistar rat pups: An in vitro study using isolated lens. Chimico-Biological Interactions, v. 181, p. 2002-2009, 2009.
MINISTÉRIO DA SAÚDE. Anvisa. Monografia da espécie Curcuma longa L. (CURCUMA). 2015. Disponível em: https://www.gov.br/anvisa/pt-br/assuntos/fitoterapicos/dados-gerais/sistema-de-apoio-a-monografias-de-fitoterapicos. Acesso em: 2023-06-22.
MURUSSI, M. et al. Nefropatia diabética no diabete melito tipo 2: fatores de risco e prevenção. Arquivos Brasileiros de Endocrinologia & Metabologia, v. 47, n. 3, p. 207-219, 2003.
NASCIMENTO, O. J. M.; PUPE, C. C. B.; CAVALCANTI, E. B. U. Neuropatia diabética. Revista Dor, v. 17, p. 46-51, 2016.
OZAWA, H. et al. Curcumin β-D-Glucuronide Plays an Important Role to Keep High Levels of Free-Form Curcumin in the Blood. Biological and Pharmaceutical Bulletin, v. 40, n. 9, p. 1515-1524, 2017.
PACHECO, Danillo dos Reis et al. Avaliação da atividade antifúngica de Curcuma longa sobre Candida parapsilosis. 2015. Disponível em: https://revistas.ufg.br/iptsp/article/view/38022/19145
PAIS, R. et al. Metabolic syndrome and risk of subsequent colorectal cancer. World Journal of Gastroenterology, v. 15, n. 41, p. 5141-5148, 2009.
PAN, M. H.; HUANG, T. M.; LIN, J. K. Biotransformation of curcumin through reduction and glucuronidation in mice. Drug Metabolism and Disposition, v. 27, n. 4, p. 486–494, 1999.
RAHMAN, I.; BISWAS, S. K.; KIRKHAM, P. A. Regulation of inflammation and redox signaling by dietary polyphenols. Biochemical Pharmacology, v. 72, n. 11, p. 1439-1452, 2006.
RAHMANI, A. H. et al. Curcumin: A Potential Candidate in Prevention of Cancer via Modulation of Molecular Pathways. BioMed Research International, v. 2014, p. 15, 2014.
RATLIFF, B. B. et al. Oxidant mechanisms in renal injury and disease. Antioxidants & Redox Signaling, v. 25, p. 119-146, 2016.
REUNANEN, A. et al. Serum antioxidants and risk of non-insulin dependent diabetes mellitus. European Journal of Clinical Nutrition, v. 52, n. 2, p. 89-93, 1998.
RODRIGUES, T. C. et al. Infecções no paciente com Diabetes Melito. Clinical & Biomedical Research, v. 30, n. 4, 2010.
RUSSO, A. et al. Metabolic syndrome and cancer risk. European Journal of Cancer, v. 44, p. 293-297, 2008.
SABRY, D.; HASSOUNA, A. A.; ABDEL-AZIZ, A. T. The effect of curcumin on insulin release in rat-isolated pancreatic islets. Angiology, v. 61, p. 557-566, 2010.
SATHYAPALAN, T.; ATKIN, S. L. Is there a role for immune and anti-inflammatory therapy in type 2 diabetes? Minerva Endocrinologica, v. 36, n. 2, p. 147-156, 2011
SCHAAN, B. D.; MANDELLI, N. C. B. Conduta na doença arterial periférica em pacientes diabéticos. Rev Soc Cardiol RGS, 2004.
SHARMA, S.; KULKARNI, S. K.; CHOPRA, K. Curcumin, the active principle of turmeric (Curcuma longa), ameliorates diabetic nephropathy in rats. India: University Institute of Pharmaceutical Sciences, 2006. Disponível em: https://onlinelibrary.wiley.com/doi/abs/10.1111/j.1440-1681.2006.04468.x
SHIN, D.; KONGPAKPAISARN, K.; BOHRA, C. Trends in the prevalence of metabolic syndrome and its components in the United States 2007-2014. Int J Cardiol. 2018;259:216–219. doi: 10.1016/j.ijcard.2018.01.139
SHOJI, M. et al. Comparison of the effects of curcumin and curcumin glucuronide in human hepatocellular carcinoma HepG2 cells. Food Chemistry. 2014;151:126–32.
SINGH, S. From exotic spice to modern drug? Cell, 2007;130:765-8.
SOCIEDADE BRASILEIRA DE HIPERTENSÃO; SOCIEDADE BRASILEIRA DE CARDIOLOGIA. I Diretriz brasileira de diagnóstico e tratamento da síndrome metabólica. Arq Bras Cardiol. 2005;84(Supl 1):1-28.
SOETIKNO, V.; AROZAL, W.; LOUISA, M.; SETIABUDY, R. New Insight into the Molecular Drug Target of Diabetic Nephropathy. Indonesia: University of Indonesia, 2014.
SOETIKNO, V. et al. Curcumin ameliorates macrophage infiltration by inhibiting NF-κB activation and proinflammatory cytokines in streptozotocin-induced diabetic nephropathy – Japan, 2011. Disponível em: https://nutritionandmetabolism.biomedcentral.com/articles/10.1186/1743-7075-8-35. Acesso em: 29-julho-2021.
SRINIVASAN, M. Effect of curcumin on blood sugar as seen in a diabetic subject. Indian Journal of Medical Sciences, v. 26, n. 4, p. 269–270, 1972.
SUNAGAWA, Y. et al. Colloidal submicron-particle curcumin exhibits high absorption efficiency: A double-blind, 3-way crossover study. J Nutr Sci Vitaminol, v. 61, n. 1, p. 37–44, 2015.
TANG, Y.; CHEN, A. Curcumin eliminates the effect of advanced glycation end-products (AGEs) on the divergent regulation of gene expression of receptors of AGEs by interrupting leptin signalling. Laboratory Investigation, v. 94, n. 5, p. 503–516, 2014.
TIAN, YM.; ZHOU, D.; ZHANG, W.; CHENG, CG. Comparison and correlative analysis of trace elements in five kinds of Radix curcumae. Guang Pu Xue Yu Guang Pu Fen Xi/Spectroscopy and Spectral Analysis, v. 28, n. 9, p. 2192-2195, 2008.
TIMERMAN, A. Infecções comuns no paciente com diabetes. 2017. Disponível em: https://veja.abril.com.br/coluna/letra-de-medico/infeccoes-comuns-no-paciente-com-diabetes/. Acesso em: 20 jul. 2022.
USHARANI, P. et al. Effect of NCB02, atorvastatin and placebo on endothelial function, oxidative stress and inflammatory markers in patients with type 2 diabetes mellitus: a randomized, parallel-group, placebo-controlled, 8-week study. Índia: Nizam's Institute of Medical Sciences, 2008.
VALKO, M.; RHODES, C. J.; MONCOL, J.; IZAKOVIC, M.; MAZUR, M. Free radicals, metals and antioxidants in oxidative stress-induced cancer. Chemico-Biological Interactions, v. 160, n. 1, p. 1-40, 2006.
VENKATESH, Sama et al. Influence of piperine on ibuprofen induced antinociception and its pharmacokinetics. Arzneimittel-Forschung, v. 61, n. 9, p. 506-509, 2011. ISSN 0004-4172.
WAHLANG, B.; PAWAR, Y. B.; BANSAL, A. K. Identification of permeability-related hurdles in oral delivery of curcumin using the Caco-2 cell model. Pharmaceutics and Biopharmaceutics, v. 77, n. 2, p. 275-282, 2011.
YU, Z. F.; KONG, L. D.; CHEN, Y. Antidepressant activity of aqueous extracts of Curcuma longa in mice. Journal of Ethnopharmacology, v. 83, n. 1-2, p. 161-165, Nov 2002.
ZHANG, D. W.; FU, M.; GAO, S. H.; LIU, J. L. Curcumin and Diabetes: A Systematic Review - Marco Leont, 2013.
HANG, L. et al. Avaliação da composição e bioativos de óleos essenciais de Curcuma longa L coletados na China. Culturas e Produtos Industriais, v. 109, p. 60-73, 2017.
Downloads
Publicado
Como Citar
Licença
Direitos de Autor (c) 2023 RECIMA21 - Revista Científica Multidisciplinar - ISSN 2675-6218
Este trabalho encontra-se publicado com a Licença Internacional Creative Commons Atribuição 4.0.
Os direitos autorais dos artigos/resenhas/TCCs publicados pertecem à revista RECIMA21, e seguem o padrão Creative Commons (CC BY 4.0), permitindo a cópia ou reprodução, desde que cite a fonte e respeite os direitos dos autores e contenham menção aos mesmos nos créditos. Toda e qualquer obra publicada na revista, seu conteúdo é de responsabilidade dos autores, cabendo a RECIMA21 apenas ser o veículo de divulgação, seguindo os padrões nacionais e internacionais de publicação.
